LINDSAY BELDEN: Open Payments
NPI 1619257474 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,394 in 73 payments from 16 companies in 2025. Trend: 2023 $1,371 · 2024 $1,577 · 2025 $1,394
Food & beverage: $1,394
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $479 |
| UCB, Inc. | 12 | $144 |
| LEO Pharma Inc. | 5 | $108 |
| Amgen Inc. | 4 | $102 |
| Arcutis Biotherapeutics, Inc. | 4 | $87 |
| Lilly USA, LLC | 4 | $80 |
| Galderma Laboratories, L.P. | 4 | $75 |
| GENZYME CORPORATION | 2 | $62 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
Products named: BOTOX, SKYRIZI, Bimzelx, OTEZLA, DUPIXENT, RINVOQ, Zoryve, ANZUPGO.
Industry payments across NC — which companies pay providers there.
